MENU
+Compare
VNRX
Stock ticker: ASE
AS OF
Jan 23, 03:45 PM (EDT)
Price
$0.63
Change
+$0.02 (+3.28%)
Capitalization
62.13M

VNRX VolitionRX Limited Forecast, Technical & Fundamental Analysis

a development stage life sciences company

VNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for VNRX with price predictions
Jan 08, 2025

Momentum Indicator for VNRX turns positive, indicating new upward trend

VNRX saw its Momentum Indicator move above the 0 level on January 08, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 97 similar instances where the indicator turned positive. In of the 97 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where VNRX advanced for three days, in of 237 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 55 cases where VNRX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

VNRX moved below its 50-day moving average on January 08, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VNRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.331) is normal, around the industry mean (23.424). P/E Ratio (0.000) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (70.922) is also within normal values, averaging (41.167).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VNRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VNRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
VNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

VNRX is expected to report earnings to fall 21.43% to -5 cents per share on March 12

VolitionRX Limited VNRX Stock Earnings Reports
Q4'24
Est.
$-0.05
Q3'24
Est.
$-0.07
Q2'24
Beat
by $0.01
Q1'24
Est.
$-0.10
Q4'23
Beat
by $0.01
The last earnings report on November 14 showed earnings per share of -7 cents, beating the estimate of -7 cents. With 29.48K shares outstanding, the current market capitalization sits at 62.13M.
A.I. Advisor
published General Information

General Information

a development stage life sciences company

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
1489 West Warm Springs Road
Phone
+1 646 650-1351
Employees
110
Web
https://www.volition.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INSP189.053.96
+2.14%
Inspire Medical Systems
AURA7.93N/A
N/A
Aura Biosciences
GSK33.43-0.35
-1.04%
GSK plc
CULP5.37-0.08
-1.47%
Culp
DVAX12.42-0.26
-2.05%
Dynavax Technologies Corp

VNRX and Stocks

Correlation & Price change

A.I.dvisor tells us that VNRX and SRDX have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VNRX and SRDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNRX
1D Price
Change %
VNRX100%
-2.98%
SRDX - VNRX
25%
Poorly correlated
-1.09%
VAPO - VNRX
25%
Poorly correlated
N/A
GENE - VNRX
23%
Poorly correlated
N/A
RMD - VNRX
23%
Poorly correlated
-0.19%
MASI - VNRX
23%
Poorly correlated
-1.65%
More